IBRX - ImmunityBio, Inc.

$7.72 as of 2026-09-10 · Healthcare · Biotechnology · Stock

IBRX (ImmunityBio, Inc.) is the #776 most-held security of 3,057 tracked on Upside Invest, held by 3 retail investors (1% of tracked portfolios), at an average allocation of 1.0% of their portfolio.

• Popularity rank: #776 of 3,057
• Holders on Upside: 3 retail investors
• Average allocation: 1.0%
• Average holder gain/loss: +8.1%
• Stock grade: B
• 30-day trading activity: 6 buys / 3 sells
• Market cap: $5.6B

Related Healthcare securities: LLY, UNH, JNJ, NVO, MRK

Holder statistics come from anonymized brokerage portfolios connected to Upside Invest. Join to compare your portfolio, or explore all securities.